Summary: Purified antibodies to human serum albumin or to human γ-globulin were used to study the direct influence of some antirheumatic drugs on the formation and disruption of immunoprecipitates. 
I-labelled human serum albumin and 125 I-labelled human IgG served as indicators. The effects of the following drugs were described: diclofenac, monophenylbutazone, diphenylbutazone, ibuprofen, and metamizol. At approximately therapeutic concentrations, the antirheumatics inhibited the formation of complexes of homologous antibodies with human serum albumin and, surprisingly, with human IgG. When the antigens were precipitated with antibodies, subsequent addition of the antirheumatics to the preformed immunoprecipitates caused disruption of [ 125 I]human serum albuminanti-human serum albumin precipitates but practically no disruption of human [
125

Introduction
Materials and Methods
Using a special radioimmunological technique (1) (2, 3) and in normal subjects, it was inci-Marburg/Germany) using, in principle, a method described predentally observed that bromophenol blue, in amounts viously (1) . The rabbits received, partly iv and partly sc, increasing exceeding 15-20 mol per mol human serum albumin, fses of either human serum albumin or human IgG every second 0 * ' day, starting from 7mg and increasing to 42 mg within 23 days; could release increasing amounts of 12:> I-labelled hu-io mg were administered on the 25th day, and the rabbits were man serum albumin from albumin-anti-alb min immu-bled on the 27th or 28th day. noprecipitates. At extremely high bromophenol blue the rabbit IgG was obtained by fractional precipitation concentrations, the precipitates were practically comwith ammonium sulphate, descending from 40 percent to 35 pletdy d is ,o,ved. Amonic antirheumatte, analgetic and ϊ^^ϊΤίΤ'ΑΑΓΟΑΑ' £ antipyretic drugs and other substances, some of which many). The ethacridin was removed with 0.85 mol/1 (50 g/1) are known for their competitive properties (4-7), were Na Cl. After dialysis of the supernatant against phosphatetherefore tested in this syseem. These drugs were con,-«f--*£ *£** Γ Ρ ±Α± 5£ pared with other substances selected at random. saturation, then dissolved in water, dialysed against 1 :9 diluted phosphate-buffered saline» and finally lyophilized. The dried rabbit IgG was dissolved in water to give 10-20 g/1 rabbit IgG solutions.
125
I-labelled human serum albumin was obtained from Amersham/Buchler (Braunschweig, Germany). Highly purified human IgG (Behringwerke, Marburg, Germany) was labelled according to the method of Hunter & Greenwood (10) . For radioiodination of 20 μg of human IgG in 1.5 ml phosphate-buffered saline, 25.5 MBq 125 I and 0.5 mg chloramine-T were used.
Inhibition and disruption experiments
In general, stock solutions (from commercial ampules or from preparations of pure substances) of the drugs were diluted 1 : 30 (or in some cases, 1 : 25,1 : 100, 1 : 1000, and 1 : 2000) with phosphate-buffered saline. Almost all experiments were run in triplicate, a few others in duplicate.
For determination of the antigen-antibody titre, constant volumes of 100 μΐ of the antibody solutions were mixed with different volumes of the corresponding 125 I-labelled antigen solution. The optimal antigen volume was read from the resulting Heidelberger precipitin curve. Immunoprecipitates with relatively loose antigen-antibody bonds were prepared by precipitation in the slight antigen excess region, i. e. at points between 80% and 45% antigen precipitation. To facilitate resuspension, the immunoprecipitates were frozen in phosphate-buffered saline at -20 °C and thawed before washing.
In the inhibition experiments using the anti-human serum albumin antibody #2/93, 10 μΐ 125 I-labelled human serum albumin solution \vere mixed with 25 μΐ drug solution, then left for 15 min at room temperature. Subsequently 50 μΐ anti-human serum albumin #2/93 were added, and the tubes incubated for 15 min at 37 °C and left to stand > l h at 8 °C.
For the controls, 25 μΐ phosphate-buffered saline were substituted for the 25 μΐ drug solution. All preparations were made up with phosphate-buffered saline pH 7.4 to a final volume of 200 μΐ and the total radioactivity was measured in a Multigamma® counter (LKB, Turku/Finland). After centrifugation at 3000 g and removal of the supernatant with a pipette, the samples were again washed and measured. For calculation, the radioactivity of the control precipitates was assigned a value of 100%.
For the disruption experiments, the immunoprecipitates were prepared first and the washing-out effect caused by the solubility of the immunocomplexes in phosphate-buffered saline was determined. The radioactivity of the washed precipitates was assigned a value of 100% and these precipitates served as controls.
In orientation experiments, it turned out that the disruption of the human serum albumin immunoprecipitates depended not only on the actual concentration of the drugs but also on the volume of the equimolar drug solution. After mixing 25 μΐ drug solution with 45 μΐ human serum albumin solution, 50 μΐ of antibody solution #2/93 were added to each sample in the centrifuge tubes. The final volume of the batches was then adjusted to 200 μΐ with phosphatebuffered saline. Accordingly, the actual concentration of the drugs was diluted 1 : 8 in the human serum albumin inhibition experiments. In order to obtain measurable values in the disruption exp eriments, however, 150 μΐ drug solution had to be added to each preformed immunoprecipitate. Thereafter, the batches were also made up with phosphate-buffered saline to a final volume of 200 μΐ, i. e. a dilution of only 3 :4. Hence, both the molar amount of the drugs (mol drug/mol human serum albumin) and the actual drug concentrations were much greater than in the inhibition experiments.
Results
As figure la shows, some antirheumatic and analgetic drugs such as metamizol, monophenylbutazone, diphenylbutazone, diclofenac, and ibuprofen, at concentrations down to the upper micromolar therapeutic range, measurably inhibit the formation of human serum albumin-anti-human serum albumin precipitates at pH 7.4 in phosphate-buffered saline solution (NaCl, 51 mmol/1; Na 2 HPO 4 , 167 mmol/1; KH 2 PO 4 , 67.5 mmol/1).
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The inhibiting drugs also disrupt some immunoprecipit ates, though in general to a much lesser extent (fig.  Ib) . The differences between inhibition of formation of immunoprecipitates and disruption of preformed precipitates suggest that the drug-binding sites of human serum albumin are only partly involved in the antigenantibody reaction. In addition, some drug-binding sites of the human serum albumin are not obstructed by immuno-binding sites of the homologous antibody. In the disruption experiments, the preformed immunoprecipitates were suspended in 150 μΐ drug solution, i. e. a volume six times larger than in the inhibition experiments. The dilution of the drug solutions by the small volume of the precipitates and phosphate-buffered saline trapped therein can therefore be ignored.
As controls for the albumin-binding experiments, the same drugs (see fig. 1 ) were used for studies on the immunoreaction between human γ-globulin and the homologous anti-y-globulin antibody. When the γ-globulin solution was incubated with the drugs first and the homologous antibody added thereafter, some inhibitory effects were observed ( fig. 2 ). These effects were quite unexpected since none of the antirheumatic drugs under investigation here is known to be bound to human γ-globulin. However, when the human γ-globulin was precipitated with the homologous antibody first, followed by incubation with anti-rheumatic drugs, the disrupting effect was negligible. This suggests that the antigen was enveloped so tightly by the homologous antibody that the drugs no longer had access to the drug-binding sites or to the immunological epitopes or paratopes of either the antigen or the antibody, or both.
Discussion
The reversible, non-specific binding of numerous substances, e. g. drugs, hormones or dye-stuffs, to human serum albumin or other plasma proteins was hitherto regarded as a unique phenomenon with some significance for the passive (9) transport of such substances from the blood stream into the organs, and vice versa. The present study shows, however, that some non-sjpecific drug binding sites of human serum albumin are identical with immunologically specific epitopes and paratopes. The inhibition by antirheumatics of antigen-antibody reactions apparently is not confined to albumin-anti-albumin precipitation, but also includes inhibition of γ-globulinanti^-globulin precipitation. In contrast to these find- ings on inhibitory effects, the disruption of preformed antigen-antibody precipitates seems essentially to be restricted to albumin-antialbumin precipitates. Thus, the bonds involved in drug adsorption are not specifically directed to drug-binding, but can also participate in immunological reactions.
Some antirheumatics other than those shown in figure 1 and 2 also disrupted immunoprecipitates or inhibited the antigen-antibody reaction, though more weakly, e. g., sod iurn salicylate, Aspirin® lysinate, indomethacin, piroxicam and chloroquine. Several non-antirheumatic drugs such as glibenclamid, promethazin, sodium oleate and potassium sorbate manifested similar activities.
Our findings using a radioimrnunological technique cannot be directly compared with the data of Rehse & Fiedler (8) who used ultrafiltration. Nevertheless, there is a striking parallel between the rank sequence order of the albumin binding values of Rehse & Fiedler and our results of immun -inhibition. For instance, these authors found particularly powerful competition values for diclofenac, ibuprofen, indomethacin and mofebutazone, whereas salicylic acid was less powerful. Common to both methods, however, are the high coefficients of variation for most drugs.
For a more direct comparison of our data with those of Rehse & Fiedler it would be necessary to calculate the apparent dissociation coefficients for both inhibition and disruption of the immunological bonds by the drugs. This will be the subject of future communications. It remains to be seen whether apparent coefficients obtained by entirely different methods can be directly compared. lead to somewhat different results. It seems therefore advisable, for future investigations, to collect large pools of antisera from different rabbits rather than to use monoclonal antibodies, since the latter may not have all desired paratopes. On the other hand, the results obtained with monoclonal antibodies would probably be more reproducible.
At present, it is not clear whether the inhibitory or disrupting effects of drugs are associated with the therapeutic efficacy or with undesirable side effects. It might be speculated that the drugs investigated so far might also inhibit immunoreactions or even disrupt immuno-complexes in vivo. This would be of importance not only with regard to possible impairment of immunological diagnostic methods, but also in the therapy of immunologically conditioned diseases. This class of diseases includes, e. g. autoimmune diseases, allergic disorders and probably also Alzheimer's disease (11, 12) in which beneficial effects of antirheumatic drugs such as indomethacin have been recently described.
However, some substances not used as drugs also possess inhibitory and disruptive properties, e. g. bromophenol blue, sodium oleate, potassium sorbate, or HEPES buffer pH 7. It may be that these substances belong to a class of "chaotropic" compounds (13) that cause inexplicable epiphenomena. Most antirheumatic drugs, however, do not possess such chaotropic properties. In any case, use of the novel simple immunological method described here may generate new information on the properties and chemical structure of drugs and other substances, and contribute to our knowledge of immunochemical bonds.
